Supplemental material
Emerging Microbes & Infections
Volume 7, 2018 - Issue 1
Related Research Data
Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues
Source:
The American Association of Immunologists
Effect of chitosan on epithelial permeability and structure.
Source:
Elsevier BV
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
Source:
Oxford University Press (OUP)
DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice.
Source:
Elsevier BV
A Randomized Clinical Trial
Source:
American Medical Association (AMA)
Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus.
Source:
Elsevier BV
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Source:
Elsevier BV
The mechanism of action of acid-soluble chitosan as an adjuvant in the formulation of nasally administered vaccine against HBV
Source:
Royal Society of Chemistry (RSC)
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).
Source:
Elsevier Inc.
The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
Source:
Springer Science and Business Media LLC
Linking provided by
